PGC
PARAGON CARE LIMITED ORDINARYParagon Care Limited distributes medical equipment, devices, and consumable products in Australia, New Zealand, and Asia. The company designs, manufactures, and distributes reagent red blood cells, monoclonal blood grouping reagents, and ancillary products for immunohematology laboratories; offers ophthalmology and optometry, neonatal vision screening solutions, and procedural kits. It also provides neonatal and paediatric assessment, including newborn hearing and vision screening, jaundice management, NICU video monitoring, brain monitoring, breast milk tracking, electrodes; sterilisable transducers designed for surgical procedures, digital theatre integration, infection control, infusion therapy, temperature management, enteral feeding, pain management, lasers, operating room products, surgical consumables, and ultrasound systems. In addition, the company offers aesthetic devices for dermatologists, cosmetic surgeons, general practitioners, beauty and aesthetic providers, and educational institutions; natural, traditional, and complementary health products and services; critical care and dental solutions; urology solutions, such as shockwave therapy, lasers, and accessories for infection control; medical products and consumables; and orthopaedics solutions, including hip and knee arthroplasty, upper and lower extremity, sports medicine, reverse shoulder replacement, and powered surgical tools. Further, it offers medical equipment repair, maintenance, and support services; technology and communication solutions, such as telephony, nurse call, access control, cctv, cordless, and Wi-Fi; supplies medical equipment to veterans, war widows, and families; and veterinary products. Additionally, it is involved in maintenance of technical medical equipment to the health, aged care, and veterinary markets; and distribution of pharmaceuticals, medical consumables, and complementary medicines to Australian healthcare market. The company is based in Mount Waverley, Australia.
PGC
PGC
PARAGON CARE LIMITED ORDINARY
Paragon Care Limited distributes medical equipment, devices, and consumable products in Australia, New Zealand, and Asia. The company designs, manufactures, and distributes reagent red blood cells, monoclonal blood grouping reagents, and ancillary products for immunohematology laboratories; offers ophthalmology and optometry, neonatal vision screening solutions, and procedural kits.
Fundamentals
Historical Data63 days
| Date | Short % | Gross Short |
|---|---|---|
| 16 July | — | — |
| 15 July | — | — |
| 14 July | — | — |
| 13 July | 0.03% | — |
| 10 July | 0.03% | — |
| 9 July | 0.03% | — |
| 8 July | 0.03% | — |
| 7 July | 0.03% | — |
| 6 July | 0.03% | — |
| 3 July | 0.03% | — |
| 2 July | 0.03% | — |
| 1 July | 0.03% | — |
Paragon Care Limited (PGC) Short Interest Summary
Paragon Care Limited (PGC) currently has 0.03% of its shares sold short (550 thousand shares, worth approximately $80K), based on ASIC short position data reported on 13 July 2026 (T+4 reporting lag). That makes PGC the #540 most shorted stock on the ASX most shorted list. Short interest in PGC is up 0.00% over the past week and up 0.00% over the past month. PGC is part of the Health Care sector on the ASX.
Recent PGC Short Position History
| Date | Short % | Short Shares | Close Price |
|---|---|---|---|
| 13 July 2026 | 0.03% | 0.6M | $0.14 |
| 10 July 2026 | 0.03% | 0.6M | $0.14 |
| 9 July 2026 | 0.03% | 0.6M | $0.14 |
| 8 July 2026 | 0.03% | 0.6M | $0.14 |
| 7 July 2026 | 0.03% | 0.6M | $0.15 |
| 6 July 2026 | 0.03% | 0.6M | $0.15 |
| 3 July 2026 | 0.03% | 0.6M | $0.16 |
| 2 July 2026 | 0.03% | 0.5M | $0.16 |
| 1 July 2026 | 0.03% | 0.5M | $0.17 |
| 30 June 2026 | 0.02% | 0.4M | $0.14 |
PGC Short Selling — Frequently Asked Questions
What is Paragon Care Limited (PGC)'s current short interest?
Paragon Care Limited (PGC) currently has a short interest of 0.03% of total shares outstanding. This means 0.03% of PGC's shares have been sold short by investors who expect the price to decline. This data is sourced from ASIC reports and updated daily.
Is PGC heavily shorted on the ASX?
PGC has a relatively low short interest of 0.03%. Short interest below 5% generally suggests limited bearish sentiment from short sellers.
What does short interest mean for PGC investors?
Short interest in PGC shows the percentage of shares investors have borrowed and sold, betting the price will fall. At 0.03%, PGC's short interest is at a low level. See our short squeeze candidates and days to cover analysis for more context.
Where does this PGC short data come from?
Short position data is published by ASIC with a four trading day delay (T+4) and covers reported short positions as a percentage of total shares on issue. ASX Short Data also tracks daily gross short sales (T+1), securities lending, and director trades for PGC.